Union européenne - français - EMA (European Medicines Agency)

les laboratoires servier - trifluridine, tipiracil de chlorhydrate de - néoplasmes colorectaux - agents antinéoplasiques - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.

Canada - français - Health Canada

apotex inc - trifluridine - solution - 1% - trifluridine 1% - antivirals

Canada - français - Health Canada

taiho pharma canada, inc. - trifluridine; tipiracil (chlorhydrate de tipiracil) - comprimé - 15mg; 6.14mg - trifluridine 15mg; tipiracil (chlorhydrate de tipiracil) 6.14mg - antineoplastic agents

Canada - français - Health Canada

taiho pharma canada, inc. - trifluridine; tipiracil (chlorhydrate de tipiracil) - comprimé - 20mg; 8.19mg - trifluridine 20mg; tipiracil (chlorhydrate de tipiracil) 8.19mg - antineoplastic agents

Canada - français - Health Canada

sandoz canada incorporated - trifluridine - solution - 1% - trifluridine 1% - antivirals

France - français - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

laboratoire chauvin - trifluridine - collyre - 1 g - composition pour 100 ml > trifluridine : 1 g

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

servier (suisse) sa - trifluridinum, tipiracilum - comprimés pelliculés - trifluridinum 15 mg, tipiracilum 6.14 mg ut tipiracili hydrochloridum, lactosum monohydricum 90.735 mg, amylum pregelificatum, acidum stearicum, pellicule: hypromellosum, macrogolum 8000, e 171, magnesii stearas, encre: lacca, e 172 (rubrum), e 172 (flavum), e 171, e 132, cera carnauba, talcum, pro compresso obducto. - cancer colorectal métastatique, cancer gastrique métastatique - synthetika

Suisse - français - Swissmedic (Swiss Agency for Therapeutic Products)

servier (suisse) sa - trifluridinum, tipiracilum - comprimés pelliculés - trifluridinum 20 mg, tipiracilum 8.19 mg ut tipiracili hydrochloridum, lactosum monohydricum 120.980 mg, amylum pregelificatum, acidum stearicum, pellicule: hypromellosum, macrogolum 8000, e 171, e 172 (rubrum), magnesii stearas, encre: lacca, e 172 (rubrum), e 172 (flavum), e 171, e 132, cera carnauba, talcum, pro compresso obducto. - cancer colorectal métastatique, cancer gastrique métastatique - synthetika

Cameroun - français - DPML (Direction de la Pharmacie du Médicament et des Laboratoires)

les laboratoires servier - trifluridine + tipiracil - comprimé pelliculé/ film coated tablet - 15 mg / 6,14 mg

Cameroun - français - DPML (Direction de la Pharmacie du Médicament et des Laboratoires)

les laboratoires servier - trifluridine + tipiracil - comprimé pelliculé/ film coated tablet - 20 mg / 8,19 mg